These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30891620)

  • 21. Sjögren SER: National registry of the Spanish Society of Rheumatology of patients with primary Sjögren syndrome: Objectives and methodology.
    Fernández Castro M; Andreu JL; Sánchez-Piedra C; Martínez Taboada V; Olivé A; Rosas J; Sánchez-Alonso F;
    Reumatol Clin; 2016; 12(4):184-9. PubMed ID: 26617051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of systemic activity of pediatric primary Sjögren's syndrome by EULAR Sjögren's syndrome disease activity index (ESSDAI).
    Kobayashi I; Okura Y; Ueki M; Tozawa Y; Takezaki S; Yamada M; Ariga T
    Mod Rheumatol; 2019 Jan; 29(1):130-133. PubMed ID: 29529894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of Autoimmune Cytopenia to Glandular and Systemic Manifestations in Primary Sjögren Syndrome: Analysis of 113 Korean Patients.
    Koh JH; Lee J; Chung SH; Kwok SK; Park SH
    J Rheumatol; 2015 Oct; 42(10):1817-24. PubMed ID: 26276967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome.
    Salman-Monte TC; Sanchez-Piedra C; Fernandez Castro M; Andreu JL; Martinez Taboada V; Olivé A; Rosas J; Menor R; Rodríguez B; Garcia Aparicio A; Lopez Longo FJ; Manrique-Arija S; Garcia Vadillo JA; Gil Barato S; López-González R; Galisteo C; Gonzalez Martin J; Ruiz Lucea E; Erausquin C; Melchor S; Moreira B; Raya E; Pego-Reigosa JM; Cid N; Júdez E; Moriano C; Narváez FJ; Corominas H; Garcia Magallon B; Guillen Astete C; Castellvi I; Bohórquez C; Loricera J; Belzunegui J; Illera Ó; Torrente-Segarra V
    Rheumatol Int; 2020 Aug; 40(8):1259-1265. PubMed ID: 32533289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of primary Sjögren's syndrome on female sexual function.
    van Nimwegen JF; Arends S; van Zuiden GS; Vissink A; Kroese FG; Bootsma H
    Rheumatology (Oxford); 2015 Jul; 54(7):1286-93. PubMed ID: 25652072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
    Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
    Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS).
    Villon C; Orgeolet L; Roguedas AM; Misery L; Gottenberg JE; Cornec D; Jousse-Joulin S; Seror R; Berthelot JM; Dieude P; Dubost JJ; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Hayem G; Le Guern V; Perdriger A; Morel J; Vittecoq O; Mariette X; Devauchelle-Pensec V; Saraux A
    Joint Bone Spine; 2021 Jul; 88(4):105162. PubMed ID: 33617999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.
    Gottenberg JE; Seror R; Miceli-Richard C; Benessiano J; Devauchelle-Pensec V; Dieude P; Dubost JJ; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Le Guern V; Morel J; Perdriger A; Puéchal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Nocturne G; Ravaud P; Mariette X
    PLoS One; 2013; 8(5):e59868. PubMed ID: 23717383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ten years of the ESSDAI: is it fit for purpose?
    de Wolff L; Arends S; van Nimwegen JF; Bootsma H
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):283-290. PubMed ID: 33095151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and safety of abatacept for the treatment of patients with primary Sjögren's syndrome.
    Machado AC; Dos Santos LC; Fidelix T; Lekwitch I; Soares SB; Gasparini AF; Augusto JV; Junior NC; Trevisani VFM
    Clin Rheumatol; 2020 Jan; 39(1):243-248. PubMed ID: 31420813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).
    Seror R; Bootsma H; Saraux A; Bowman SJ; Theander E; Brun JG; Baron G; Le Guern V; Devauchelle-Pensec V; Ramos-Casals M; Valim V; Dörner T; Tzioufas A; Gottenberg JE; Solans Laqué R; Mandl T; Hachulla E; Sivils KL; Ng WF; Fauchais AL; Bombardieri S; Priori R; Bartoloni E; Goeb V; Praprotnik S; Sumida T; Nishiyama S; Caporali R; Kruize AA; Vollenweider C; Ravaud P; Meiners P; Brito-Zerón P; Vitali C; Mariette X;
    Ann Rheum Dis; 2016 Feb; 75(2):382-9. PubMed ID: 25480887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity.
    Dörner T; Posch MG; Li Y; Petricoul O; Cabanski M; Milojevic JM; Kamphausen E; Valentin MA; Simonett C; Mooney L; Hüser A; Gram H; Wagner FD; Oliver SJ
    Ann Rheum Dis; 2019 May; 78(5):641-647. PubMed ID: 30826774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of enthesopathy in patients with primary Sjogren's syndrome: ultrasonographic study of a local cohort.
    Sag S; Sag MS; Tekeoglu I; Kamanlı A; Nas K
    J Med Ultrason (2001); 2018 Jan; 45(1):121-127. PubMed ID: 28646319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren's syndrome patients.
    Bai W; Yang F; Xu H; Wei W; Li H; Zhang L; Zhao Y; Shi X; Zhang Y; Zeng X; Leng X
    Trials; 2023 Feb; 24(1):112. PubMed ID: 36793118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients.
    Brito-Zerón P; Kostov B; Solans R; Fraile G; Suárez-Cuervo C; Casanovas A; Rascón FJ; Qanneta R; Pérez-Alvarez R; Ripoll M; Akasbi M; Pinilla B; Bosch JA; Nava-Mateos J; Díaz-López B; Morera-Morales ML; Gheitasi H; Retamozo S; Ramos-Casals M;
    Ann Rheum Dis; 2016 Feb; 75(2):348-55. PubMed ID: 25433020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do antimalarials protect against damage accrual in primary Sjögren's syndrome? Results from a Latin-American retrospective cohort.
    Hernández-Molina G; Valim V; Secco A; Atisha-Fregoso Y; Guerra E; Adrover M; Lage Santos AJ; Catalán-Pellet A
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):182-185. PubMed ID: 29745873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study.
    de Frémont GM; Costedoat-Chalumeau N; Lazaro E; Belkhir R; Guettrot-Imbert G; Morel N; Nocturne G; Molto A; Goulenok T; Diot E; Perard L; Ferreira-Maldent N; Le Besnerais M; Limal N; Martis N; Abisror N; Debouverie O; Richez C; Sobanski V; Maurier F; Sauvetre G; Levesque H; Timsit MA; Tieulié N; Orquevaux P; Bienvenu B; Mahevas M; Papo T; Lartigau-Roussin C; Chauvet E; Berthoux E; Sarrot-Reynauld F; Raffray L; Couderc M; Silva NM; Jourde-Chiche N; Belhomme N; Thomas T; Poindron V; Queyrel-Moranne V; Delforge J; Le Ray C; Pannier E; Mariette X; Le Guern V; Seror R;
    Lancet Rheumatol; 2023 Jun; 5(6):e330-e340. PubMed ID: 38251600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
    Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
    Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.
    Olsson P; Bodewes ILA; Nilsson AM; Turesson C; Jacobsson LTH; Theander E; Versnel MA; Mandl T
    Rheumatol Int; 2019 Sep; 39(9):1575-1584. PubMed ID: 31139950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry).
    Flores-Chávez A; Kostov B; Solans R; Fraile G; Maure B; Feijoo-Massó C; Rascón FJ; Pérez-Alvarez R; Zamora-Pasadas M; García-Pérez A; Lopez-Dupla M; Duarte-Millán MÁ; Ripoll M; Fonseca-Aizpuru E; Guisado-Vasco P; Pinilla B; de-la-Red G; Chamorro AJ; Morcillo C; Fanlo P; Soto-Cárdenas MJ; Retamozo S; Ramos-Casals M; Brito-Zerón P;
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):121-129. PubMed ID: 30156546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.